FDA Approves Tecvayli (teclistamab-cqyv) for the Treatment of Relapsed or Refractory Multiple Myeloma Patients (https://www.myeloma.org/news-events/multiple-myeloma-news/fda-approves-tecvayli-teclistimab-relapsed-refractory-myeloma)